Matushak Jay 4

4 · NeueHealth, Inc. · Filed Mar 11, 2025

Form 4

Period: 2025-03-07

Chief Financial Officer

Transactions

Sale
Common Stock
2025-03-07$7.19/sh−1,860$13,373→ 22,227 total
Sale
Common Stock
2025-03-10$7.06/sh−184$1,299→ 24,487 total
Exercise/Conversion
Restricted Stock Units
2025-03-07−2,444→ 0 total
→ Common Stock (2,444 underlying)
Exercise/Conversion
Common Stock
2025-03-07+2,444→ 24,671 total

Footnotes (5)

[F1]These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person.
[F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.10 and $7.25 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
[F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.90 and $7.18 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F5]These restricted stock units vested in three equal annual installments beginning on March 7, 2023.

Documents

1 file